DSM Capital Partners’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $134K | Hold |
|
|||||
|
2018
Q2 | $120K | Hold |
|
|||||
|
2018
Q1 | $107K | Sell |
|
|||||
|
2017
Q4 | $90.7M | Sell |
|
|||||
|
2017
Q3 | $198M | Buy |
|
|||||
|
2017
Q2 | $142M | Buy |
|
|||||
|
2017
Q1 | $123M | Sell |
|
|||||
|
2016
Q4 | $136M | Sell |
|
|||||
|
2016
Q3 | $143M | Sell |
|
|||||
|
2016
Q2 | $153M | Sell |
|
|||||
|
2016
Q1 | $190M | Sell |
|
|||||
|
2015
Q4 | $262M | Buy |
|
|||||
|
2015
Q3 | $195M | Sell |
|
|||||
|
2015
Q2 | $228M | Buy |
|
|||||
|
2015
Q1 | $162M | Sell |
|
|||||
|
2014
Q4 | $294M | Sell |
|
|||||
|
2014
Q3 | $265M | Buy |
|
|||||
|
2014
Q2 | $249M | Buy |
|
|||||
|
2014
Q1 | $156M | Sell |
|
|||||
|
2013
Q4 | $174M | Buy |
|
|||||
|
2013
Q3 | $122M | Sell |
|
|||||
|
2013
Q2 | $122M | Buy |
|